Ignite Creation Date:
2024-05-05 @ 11:32 AM
Last Modification Date:
2024-10-26 @ 9:09 AM
Study NCT ID:
NCT00075049
Status:
COMPLETED
Last Update Posted:
2014-08-21
First Post:
2003-12-31
Brief Title:
Safety and Efficacy Study of RTSS AS02AAS01B Vaccine to Prevent Malaria
Sponsor:
US Army Medical Research and Development Command
Organization:
US Army Medical Research and Development Command
Study Overview
Official Title:
Dbl-Blind Rand Phase 12a Human Challenge Study to Eval Safety Reactogenicity Immunogenicity and Preliminary Efficacy After Sporozoite ChallengeRechallenge of Vaccines Containing RTSS
Status:
COMPLETED
Status Verified Date:
2014-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is a double blinded study where 2 test vaccines will be evaluated to see if they protect persons who have never had malaria against malaria infection when bitten by mosquitoes
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 257049027 | None | None | None |
| HSRRB A-12227 | None | None | None |